Walleye Trading
SLNO

Walleye Trading’s Soleno Therapeutics SLNO Stock Holding History

Walleye Trading’s Portfolio SLNO Stock Details SLNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-10,100
Closed -$468K – 4669
2025
Q4 		$468K Buy
10,100
+7,500
+288% +$411K ﹤0.01% 2866
2025
Q3 		$176K Buy
+2,600
New +$193K ﹤0.01% 3430

Other funds holding SLNO

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
KCM
Khrom Capital Management Miami Beach, Florida $1.09B AUM 14.82% 1-Year Est. Return

Walleye Trading's SLNO Position: Q1 2026 in Review

Walleye Trading sold out of Soleno Therapeutics (SLNO) in Q1 2026, closing a stake of 6,521 shares — an estimated $302K sold.

Walleye Trading first reported a position in SLNO in Q2 2025 and held it in 2 quarters. The position peaked at $302K in Q4 2025. 225 funds tracked by Wall St. Rank hold SLNO as of Q1 2026.

  • Walleye Trading reported no remaining Soleno Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Walleye Trading sold 6,521 Soleno Therapeutics shares in Q1 2026, an estimated $302K.
  • Walleye Trading first reported a position in Soleno Therapeutics in Q2 2025 and held it in 2 quarters.
  • Walleye Trading's Soleno Therapeutics position peaked at $302K in Q4 2025.
  • 225 funds tracked by Wall St. Rank held Soleno Therapeutics as of Q1 2026.

Based on Walleye Trading's 13F filing for Q1 2026, filed 11 May 2026.